[Recommendations in the empiric anti-infective agents of intra-abdominal infection].
A significant number of patients with abdominal infection develop advanced stages of infection and mortality is still above 20%. Failure is multifactorial and is associated with an increase of bacterial resistance, inappropriate empirical treatment, a higher comorbidity of patients and poor source control of infection. These guidelines discuss each of these problems and propose measures to avoid the failure based on the best current scientific evidence.
Guirao
X
X
Sección de Infección Quirúrgica, Asociación Española de Cirujanos, Madrid. xguirao@teleline.es
Arias
J
J
Badía
J M
JM
García-Rodríguez
J A
JA
Mensa
J
J
Alvarez-Lerma
F
F
Borges
M
M
Barberán
J
J
Maseda
E
E
Salavert
M
M
Llinares
P
P
Gobernado
M
M
García Rey
C
C
D000005:Abdomen; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D011183:Postoperative Complications / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents